Cheelcare Announces $1.5M Private Placement Priced at 129% Premium to OTC Shares
Summary
Cheelcare announced a non-brokered private placement to raise up to $1.5 million. Units are priced at $1.50, which is a substantial 129% premium to the current OTC share price of $0.6551. This strong investor commitment follows recent positive developments, including a new patent and record product bookings. The capital will fund continued product development and commercialization activities.
At the time of this announcement, CHCRF was trading at $0.66 on OTC in the Life Sciences sector. The 52-week trading range was $0.66 to $0.66. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: TMX Newsfile.